{"disease":{"id":"lung-cancer-nonsmall-cell","name":"lung cancer nonsmall cell"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06996249","title":"Prospective Data Collection Initiative on Thoracic Malignancies","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Dutch Society of Physicians for Pulmonology and Tuberculosis","has_results":false},{"nct_id":"NCT05537922","title":"I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy","phase":"","overall_status":"RECRUITING","enrollment_count":2200,"lead_sponsor_name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","has_results":false},{"nct_id":"NCT05085028","title":"A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1750,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT06293833","title":"Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan","phase":"NA","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"University Hospital, Antwerp","has_results":false},{"nct_id":"NCT03059641","title":"Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Geneplus-Beijing Co. Ltd.","has_results":false},{"nct_id":"NCT03504098","title":"Folate One-carbon Malnutrition as the Metabostemness Risk Factor of Malignancy Tumor Development of NSCLC Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT04237805","title":"A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":280,"lead_sponsor_name":"Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.","has_results":false},{"nct_id":"NCT04611867","title":"Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)","phase":"NA","overall_status":"RECRUITING","enrollment_count":274,"lead_sponsor_name":"Inna Chen, MD","has_results":false},{"nct_id":"NCT05014815","title":"Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":272,"lead_sponsor_name":"BeiGene","has_results":true},{"nct_id":"NCT06319950","title":"High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":255,"lead_sponsor_name":"Taizhou Hospital","has_results":false},{"nct_id":"NCT04566432","title":"Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Geneplus-Beijing Co. Ltd.","has_results":false},{"nct_id":"NCT02562027","title":"SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":217,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT06405815","title":"A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Jinling Hospital, China","has_results":false},{"nct_id":"NCT03838588","title":"The Tracking Molecular Evolution for NSCLC (T-MENC) Study","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Geneplus-Beijing Co. Ltd.","has_results":false},{"nct_id":"NCT04631731","title":"Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Western Sydney Local Health District","has_results":false},{"nct_id":"NCT05384873","title":"Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT03258671","title":"IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"LuBing","has_results":false},{"nct_id":"NCT06231680","title":"Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":132,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT05472350","title":"Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After Lobectomy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":128,"lead_sponsor_name":"Jianxing He","has_results":false},{"nct_id":"NCT03689634","title":"Move For Surgery - A Novel Preconditioning Program","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"St. Joseph's Healthcare Hamilton","has_results":false},{"nct_id":"NCT03044626","title":"Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"AIO-Studien-gGmbH","has_results":false},{"nct_id":"NCT03444766","title":"Study of Nivolumab for Advanced Cancers in India","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT04981938","title":"Pulmonary Function After Arterial Sleeve Lobectomy","phase":"","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"Centre Hospitalier Régional Universitaire Montpellier","has_results":false},{"nct_id":"NCT03499678","title":"Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA","phase":"","overall_status":"TERMINATED","enrollment_count":81,"lead_sponsor_name":"HKGepitherapeutics","has_results":false},{"nct_id":"NCT06426511","title":"ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03846310","title":"A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"Arcus Biosciences, Inc.","has_results":false},{"nct_id":"NCT05358249","title":"Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":74,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04900935","title":"Patient-centered, Optimal Integration of Survivorship and Palliative Care","phase":"NA","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT05725915","title":"Prediction Model of ICIs Combined With Chemotherapy in Advanced NSCLC","phase":"","overall_status":"UNKNOWN","enrollment_count":56,"lead_sponsor_name":"Beijing Red Clove Public Welfare Development Center","has_results":false},{"nct_id":"NCT03704870","title":"Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT03415126","title":"A Study of ASN007 in Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Asana BioSciences","has_results":false},{"nct_id":"NCT02905591","title":"A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":43,"lead_sponsor_name":"Joseph J. Cullen, MD, FACS","has_results":false},{"nct_id":"NCT05158530","title":"Effect of Exercise Training in Lung Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Riphah International University","has_results":false},{"nct_id":"NCT05956782","title":"Breathe Easier II: A Dyad-based Multiple Behavior Intervention","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"University of South Carolina","has_results":false},{"nct_id":"NCT04740047","title":"Cios Mobile 3D Spin for Robotic Bronchoscopy","phase":"","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03380871","title":"A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"BioNTech US Inc.","has_results":false},{"nct_id":"NCT05860296","title":"Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":36,"lead_sponsor_name":"SignalChem Lifesciences Corporation","has_results":false},{"nct_id":"NCT04634630","title":"The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung","phase":"","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Beatrice Aramini","has_results":false},{"nct_id":"NCT06667154","title":"Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With Chemotherapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":33,"lead_sponsor_name":"Aline Fusco Fares, MD","has_results":false},{"nct_id":"NCT02786589","title":"Plasmodium Immunotherapy for Lung Cancer","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"State Key Laboratory of Respiratory Disease","has_results":false},{"nct_id":"NCT03322072","title":"Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating","phase":"NA","overall_status":"UNKNOWN","enrollment_count":28,"lead_sponsor_name":"CancerCare Manitoba","has_results":false},{"nct_id":"NCT03902834","title":"Move for Surgery (MFS): Evaluating the Use of Wearable Technology for Preconditioning Before Thoracic Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"St. Joseph's Healthcare Hamilton","has_results":false},{"nct_id":"NCT06060964","title":"Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom Management","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":24,"lead_sponsor_name":"University of South Carolina","has_results":false},{"nct_id":"NCT05061940","title":"This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.","phase":"","overall_status":"TERMINATED","enrollment_count":22,"lead_sponsor_name":"Repertoire Immune Medicines","has_results":false},{"nct_id":"NCT02299141","title":"Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT04314895","title":"Trial of NanoPac Intratumoral Injection in Lung Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"NanOlogy, LLC","has_results":true},{"nct_id":"NCT02193152","title":"Pazopanib in Molecularly Selected Patients With Advanced NSCLC","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":16,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT02991651","title":"Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Io Therapeutics","has_results":false},{"nct_id":"NCT02342353","title":"Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04638582","title":"Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}